Improvements in HIV treatment outcomes among indigenous and non indigenous people who use illicit drugs in a Canadian setting
In many settings worldwide, members of indigenous groups experience a disproportionate burden of HIV. In Canada, there is an urgent need to improve HIV treatment outcomes for indigenous people living with HIV (IPLWH) to not only reduce HIV/AIDS associated morbidity and mortality but also curb elevated rates of viral transmission. Thus, by comparing indigenous and non indigenous participants in an ongoing longitudinal cohort of HIV positive people who use illicit drugs, we sought to investigate longitudinal changes in three HIV treatment indicators for IPLWH who use illicit drugs during a community wide treatment as prevention (TasP) initiative in British Columbia, Canada.
Journal of the International AIDS Society